entertainment -WSS

entertainment

author：Wikipedia 2025-09-02 08:14:30 - browse：76

Anthony Fernandez holds a Wegovy injection, the ALP-1 agonist medication he uses to help curb his food cravings – Obesity medication and science coverage for STAT — A person holds a Wegovy injection pen. Kayana Szymczak for STAT

Medicare confirmed this week that it will cover Novo Nordisk’s obesity drug Wegovy if prescribed to prevent heart problems, but policy experts said Medicare patients are still likely to encounter significant barriers getting access to the highly popular and expensive drug.

Medicare previously wasn’t reimbursing for Wegovy, since the federal payer is legally barred from covering weight loss drugs. But the Food and Drug Administration this month approved Wegovy for preventing heart problems in people with obesity and heart disease, leading many to suspect that Medicare would start covering the drug for this usage.

Makers of obesity drugs have been hoping that showing additional benefits beyond weight loss would induce more insurers to cover them. Medicare’s guidance, first reported Thursday, moves in that direction, but experts point out that the private insurers that administer Medicare’s prescription drug benefit — called Part D — can still choose to not include Wegovy on their formularies, especially if they think it would be too costly.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： What does generative AI mean for health care? We asked experts
Next article： Patients, doctors press FTC to beef up hospital merger scrutiny

WSS

White House Covid adviser calls on docs to combat misinformation

FDA panel to weigh safety of artificial wombs for preterm births

Drone hits Crimean ammunition depot as strikes kill, wound civilians and journalists in Ukraine

Where does female orgasm come from? Scientists think they know

Hundreds of thousands march in Israel. Former security chiefs beg Netanyahu to halt legal overhaul

Statins reduce cardiovascular risk in people living with HIV

focus

entertainment

knowledge

Heart attack and stroke risk calculators need revising

How a key Senate committee is planning to regulate PBMs

Bright Health sells Medicare Advantage business to Molina

Sophia Smith scores twice for US in in 3

Bright Health sells Medicare Advantage business to Molina

David Liu startup to focus on CRISPR delivery

After affirmative action ruling, medical educators look to 'holistic review'

What happened to the House vote on health price transparency?

After affirmative action ruling, medical educators look to 'holistic review'

Midwives could help bridge maternal health disparities in the U.S.

focus

'A game

Patients, doctors press FTC to beef up hospital merger scrutiny

'The Earth is screaming at us': Gov. Inslee calls for climate action amid record heat

Clinic falsely told dozens they had Alzheimer's, suits say

Neurocrine congenital adrenal hyperplasia trial succeeds

Inside the culture of fear in the White House science office of Eric Lander

hotspot

entertainment

leisure time

hotspot